Technical Analysis for GWPRF - GW Pharmaceuticals plc

Grade Last Price % Change Price Change
grade A 10.9 19.78% 1.8000
GWPRF closed up 19.78 percent on Wednesday, July 8, 2020, on 3.01 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical GWPRF trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Crossed Above 200 DMA Bullish 0.00%
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Centerline Cross Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
20 DMA Resistance Bearish 19.78%
Fell Below 200 DMA Bearish 19.78%
Fell Below 50 DMA Bearish 19.78%
Older signals for GWPRF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

GW is a pharmaceutical group developing a portfolio of cannabinoid prescription medicines to meet patient needs in a wide range of therapeutic conditions. GW is licensed by the UK Home Office to work with a range of controlled drugs for medical research purposes. The Group's lead programme is the development of a product portfolio of cannabinoid prescription medicines , including Sativex® Oromucosal Spray, to meet patient needs in a wide range of therapeutic indicationsGW has assembled a large in-house team with extensive experience in developing cannabinoids, medicines containing controlled substances, as well as plant-based prescription pharmaceutical products. GW also holds GMP manufacturing licences for the manufacture of pharmaceutical products for both clinical trials and commercial purposes.
Health Drugs Pharmaceutical Pharmacy Medication Pharmaceuticals Policy Pharmaceutical Products Pharmaceutical Sciences Cannabinoids Medical Prescription Clinical Pharmacology Prescription Drug Nabiximols

Is GWPRF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.72
52 Week Low 4.48
Average Volume 1,694
200-Day Moving Average 9.1179
50-Day Moving Average 9.7975
20-Day Moving Average 10.0455
10-Day Moving Average 9.9930
Average True Range 1.0765
ADX 31.25
+DI 13.1174
-DI 33.3198
Chandelier Exit (Long, 3 ATRs ) 8.0205
Chandelier Exit (Short, 3 ATRs ) 11.5795
Upper Bollinger Band 11.1930
Lower Bollinger Band 8.8980
Percent B (%b) 0.87
BandWidth 22.8461
MACD Line 0.0354
MACD Signal Line 0.0554
MACD Histogram -0.02
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.8750
Resistance 3 (R3) 11.7667 11.3333 11.7125
Resistance 2 (R2) 11.3333 11.0850 11.3875 11.6583
Resistance 1 (R1) 11.1167 10.9316 11.2250 11.2250 11.6041
Pivot Point 10.6833 10.6833 10.7375 10.7375 10.6833
Support 1 (S1) 10.4667 10.4350 10.5750 10.5750 10.1959
Support 2 (S2) 10.0333 10.2816 10.0875 10.1417
Support 3 (S3) 9.8167 10.0333 10.0875
Support 4 (S4) 9.9250